IP Library › Assignment 063874/0250
Patent Assignment
Reel/Frame 063874/0250

Change of Address for Assignee

Recorded: 2023-03-31 Pages: 4
Assignor
Assignee
PFIZER INC./RINAT NEUROSCIENCE CORP.
66 HUDSON BOULEVARD EAST, LEGAL PATENT DEPT, CHIEF IP COUNSEL, NEW YORK, NEW YORK, 10001-2192
Covered Properties (8)
An Isolated Antibody Which Specifically Binds to PCSK9
Patent: 8,080,243 →
Application: 12/558,312 →
Publication: US 2010/0068199
An Isolated Nucleic Acid Encoding an Antibody Which Specifically Binds to PCSK9 and a Host Cell That Produces the Antibody
Patent: 8,399,646 →
Application: 13/225,119 →
Publication: US 2012/0015435
A Method for Reducing a Level of Ldl-Cholesterol by an Antibody That Specifically Binds to PCSK9
Patent: 8,426,363 →
Application: 13/225,265 →
Publication: US 2012/0014951
PCSK9 Antagonists
Patent: 9,175,093 →
Application: 13/857,063 →
Publication: US 2013/0273069
Engineered Polypeptide Conjugates and Methods for Making Thereof Using Transglutaminase
Patent: 9,676,871 →
Application: 13/883,535 →
Publication: US 2013/0230543
Antibody-Drug Conjugates with High Drug Loading
Application: 15/306,481 →
Publication: US 2017/0043033
Engineered Polypeptide Conjugates and Methods for Making Thereof Using Transglutaminase
Application: 15/593,259 →
Publication: US 2017/0313787
Engineered Polypeptide Conjugates and Methods for Making Thereof Using Transglutaminase
Application: 16/951,003 →
Publication: US 2021/0115159